. 2022 Jan 22;14(2):262. doi: 10.3390/pharmaceutics14020262

Table 3.

The enhancement efficacy parameters of enhancers in the drug release and skin penetration process.

	ER_release	ER_permeation	ER_com	β_R/P	ER_{solution retention}	ER_{hydrogel retention}	F_P/Q
LicA-CP 90	0.89	2.72	1.18	0.33	2.70	1.13	0.015
LicA-IPM	1.05	2.91	0.00	0.36	3.30	0.68	0.00
LicA-NMP	1.21	1.08	0.00	1.12	0.54	0.76	0.00
LicA-PG	1.25	0.55	1.10	2.28	1.23	1.82	0.0099
LicA-POCC	0.89	3.09	1.46	0.29	3.28	0.65	0.018
LicA-SP	1.02	2.77	1.12	0.37	3.78	0.99	0.012
LicA-TP	1.00	1.50	1.92	0.67	1.44	1.23	0.022
Gla-CP 90	1.07	2.93	1.40	0.36	2.11	1.39	0.022
Gla-IPM	1.08	1.15	0.86	0.94	1.49	1.51	0.014
Gla-NMP	1.14	2.20	0.78	0.52	1.47	1.28	0.012
Gla-PG	1.11	0.68	1.28	1.63	1.31	1.11	0.020
Gla-POCC	1.06	2.16	2.05	0.49	1.28	1.79	0.033
Gla-SP	1.14	1.15	1.14	0.99	1.04	1.90	0.017
Gla-TP	1.15	1.38	0.72	0.83	1.51	1.14	0.011